CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...
Findings identify strategy for boosting anticancer immunity and potentially a new tool for delivering genetic payloads to ...
A new study published in Engineering provides mechanistic insights into live-cell glycocalyx engineering and supports the rational design of next-generation adoptive cell therapies (ACTs) against B ...
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's ...
Study in adults and children with aplastic anemia identifies parallel evolutionary pathways used by hematopoietic stem cells ...
Emirates News Agency on MSN
Scientists recruit red blood cells to deliver genetic cargo with instructions to kill cancer
BEIJING, 1st May, 2026 (WAM) — Scientists have developed a way to turn the body's own immune cells into cancer-fighting agents—without removing them from the body—by using red blood cells to deliver ...
Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results